HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.

Abstract
A novel way of chemical modification of the antibiotic olivomycin I at the 2'-keto group of the side chain of the aglycone moiety was developed. Reaction of olivomycin I with the carboxymethoxylamine hemihydrochloride gave the key intermediate, 2'-carboxymethoxime-olivomycin I, which was further reacted with different amines in the presence of benzotriazol-1-yl-oxy-trispyrrolidinophosphonium hexafluorophosphate to give the corresponding amides. The antiproliferative and topoisomerase I (Topo-I)-poisoning activities of the novel derivatives were examined. One of the novel derivatives showed a marked inhibitory activity against Topo-I, a pronounced antitumor activity in in vivo experiments on mice bearing leukemia P-388 and lower toxic side effects compared with the parent olivomycin I.
AuthorsAnna N Tevyashova, Eugenia N Olsufyeva, Eugenia N Zbarsky, Jan Balzarini, Alexander A Shtil, Lyubov G Dezhenkova, Vladimir M Bukhman, Victor B Zbarsky, Maria N Preobrazhenskaya
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 62 Issue 1 Pg. 37-41 (Jan 2009) ISSN: 1881-1469 [Electronic] England
PMID19132061 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Enzyme Inhibitors
  • Ketones
  • Topoisomerase I Inhibitors
  • Olivomycins
Topics
  • Animals
  • Antibiotics, Antineoplastic (chemical synthesis, chemistry, pharmacology)
  • Carbohydrate Sequence
  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Chromatography, Thin Layer
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Humans
  • Ketones (chemistry)
  • Leukemia P388
  • Male
  • Mass Spectrometry
  • Mice
  • Molecular Sequence Data
  • Olivomycins (chemical synthesis, chemistry, pharmacology)
  • Topoisomerase I Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: